A 12-Month-Interval Dosing Study in Adults Indicates That a Single Dose of the National Institute of Allergy and Infectious Diseases Tetravalent Dengue Vaccine Induces a Robust Neutralizing Antibody Response.

A 12-Month-Interval Dosing Study in Adults Indicates That a Single Dose of the National Institute of Allergy and Infectious Diseases Tetravalent Dengue Vaccine Induces a Robust Neutralizing Antibody Response.

Item
http://www.wikidata.org/entity/Q40116968
Development of a Zika vaccineVaccination strategies against Zika virusIn a randomized trial, the live attenuated tetravalent dengue vaccine TV003 is well-tolerated and highly immunogenic in subjects with flavivirus exposure prior to vaccinationEvaluation of protection induced by a dengue virus serotype 2 envelope domain III protein scaffold/DNA vaccine in non-human primates.Immune correlates of protection for dengue: State of the art and research agenda.Potential for treatment and a Zika virus vaccine.A dose-response study in mice of a tetravalent vaccine candidate composed of domain III-capsid proteins from dengue viruses.Dengue Vaccine: The Need, the Challenges, and Progress.Immunogenicity of the CYD tetravalent dengue vaccine using an accelerated schedule: randomised phase II study in US adults
P2860

A 12-Month-Interval Dosing Study in Adults Indicates That a Single Dose of the National Institute of Allergy and Infectious Diseases Tetravalent Dengue Vaccine Induces a Robust Neutralizing Antibody Response.

Item
http://www.wikidata.org/entity/Q40116968
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
A 12-Month-Interval Dosing Stu ...... eutralizing Antibody Response.
@en
type
label
A 12-Month-Interval Dosing Stu ...... eutralizing Antibody Response.
@en
prefLabel
A 12-Month-Interval Dosing Stu ...... eutralizing Antibody Response.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
A 12-Month-Interval Dosing Stu ...... eutralizing Antibody Response.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932